Brain Stimulation for Working Memory
Trial Summary
What is the purpose of this trial?
This study will use novel transcranial alternating current stimulation (tACS) protocols and electroencephalography (EEG) to modulate and measure brain oscillations that underlie working memory. tACS is a noninvasive method used to modulate the timing and patterns of brain rhythms via weak electric currents passed through electrodes on the scalp.
Will I have to stop taking my current medications?
Yes, you will need to stop taking certain medications, especially those that affect brain stimulation, like psychotropic drugs and others that alter brain chemicals. It's best to discuss your specific medications with the trial team.
What data supports the effectiveness of the treatment Transcranial Alternating Current Stimulation (tACS) for improving working memory?
Research suggests that tACS can have small-to-medium positive effects on working memory, especially when using specific frequencies like theta and gamma. These effects have been observed in both healthy adults and those with cognitive deficits, indicating potential for tACS as a non-drug method to enhance cognitive performance.12345
Is transcranial alternating current stimulation (tACS) safe for humans?
How does the treatment Active tACS differ from other treatments for working memory issues?
Active tACS (Transcranial Alternating Current Stimulation) is unique because it uses specific frequencies to modulate brain waves, potentially enhancing working memory by aligning with natural brain oscillations. Unlike other treatments, it is non-invasive, cost-effective, and has a promising safety profile, making it an attractive option for cognitive enhancement, especially in older adults and those with cognitive deficits.12359
Eligibility Criteria
This trial is for individuals who can give informed consent and are fluent in English. It's designed to explore how working memory functions by using a noninvasive brain stimulation technique.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo four tACS sessions with EEG recording before and after each session
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Active tACS (Device)
- Placebo tACS (Device)
Active tACS is already approved in United States, European Union for the following indications:
- Investigational for cognitive rehabilitation in neurodegenerative diseases and aging-related cognitive decline
- Investigational for cognitive rehabilitation in neurodegenerative diseases and aging-related cognitive decline